EXANE DERIVATIVES - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$10,618,000
-0.3%
8740.0%0.00%0.0%
Q4 2021$10,645,000
-21.2%
8740.0%0.00%0.0%
Q3 2021$13,503,000
+14.9%
8740.0%0.00%0.0%
Q2 2021$11,755,000
-50.1%
874
-19.5%
0.00%
-57.1%
Q1 2021$23,576,000
-2.7%
1,086
-32.2%
0.01%0.0%
Q4 2020$24,222,000
+18.9%
1,6010.0%0.01%
+16.7%
Q3 2020$20,372,000
-25.6%
1,6010.0%0.01%
-14.3%
Q2 2020$27,375,000
+29.4%
1,6010.0%0.01%
+16.7%
Q1 2020$21,148,000
-84.4%
1,601
-80.2%
0.01%
-76.0%
Q4 2019$135,515,000
-58.8%
8,069
-55.2%
0.02%
-57.6%
Q3 2019$329,233,000
-23.5%
18,014
-10.0%
0.06%
-21.3%
Q2 2019$430,114,000
+223.1%
20,013
+194.9%
0.08%
+188.5%
Q1 2019$133,109,000
+42.3%
6,787
-5.7%
0.03%
+52.9%
Q4 2018$93,571,000
-45.7%
7,2000.0%0.02%
-46.9%
Q3 2018$172,376,000
+25.1%
7,2000.0%0.03%
+39.1%
Q2 2018$137,822,0007,2000.02%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders